TY - JOUR
T1 - Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5
AU - Loh, Nellie Y.
AU - Bentley, Liz
AU - Dimke, Henrik
AU - Verkaart, Sjoerd
AU - Tammaro, Paolo
AU - Gorvin, Caroline M.
AU - Stechman, Michael J.
AU - Ahmad, Bushra N.
AU - Hannan, Fadil M.
AU - Piret, Sian E.
AU - Evans, Helen
AU - Bellantuono, Ilaria
AU - Hough, Tertius A.
AU - Fraser, William D.
AU - Hoenderop, Joost G. J.
AU - Ashcroft, Frances M.
AU - Brown, Steve D. M.
AU - Bindels, Rene J. M.
AU - Cox, Roger D.
AU - Thakker, Rajesh V.
N1 - © 2013 Loh et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2013/1/30
Y1 - 2013/1/30
N2 - Hypercalciuria is a major cause of nephrolithiasis, and is a common and complex disorder involving genetic and environmental factors. Identification of genetic factors for monogenic forms of hypercalciuria is hampered by the limited availability of large families, and to facilitate such studies, we screened for hypercalciuria in mice from an N-ethyl-N-nitrosourea mutagenesis programme. We identified a mouse with autosomal dominant hypercalciuria (HCALC1). Linkage studies mapped the Hcalc1 locus to a 11.94 Mb region on chromosome 6 containing the transient receptor potential cation channel, subfamily V, members 5 (Trpv5) and 6 (Trpv6) genes. DNA sequence analysis of coding regions, intron-exon boundaries and promoters of Trpv5 and Trpv6 identified a novel T to C transition in codon 682 of TRPV5, mutating a conserved serine to a proline (S682P). Compared to wild-type littermates, heterozygous (Trpv5) and homozygous (Trpv5) mutant mice had hypercalciuria, polyuria, hyperphosphaturia and a more acidic urine, and ~10% of males developed tubulointerstitial nephritis. Trpv5 mice also had normal plasma parathyroid hormone but increased 1,25-dihydroxyvitamin D concentrations without increased bone resorption, consistent with a renal defect for the hypercalciuria. Expression of the S682P mutation in human embryonic kidney cells revealed that TRPV5-S682P-expressing cells had a lower baseline intracellular calcium concentration than wild-type TRPV5-expressing cells, suggesting an altered calcium permeability. Immunohistological studies revealed a selective decrease in TRPV5-expression from the renal distal convoluted tubules of Trpv5 and Trpv5 mice consistent with a trafficking defect. In addition, Trpv5 mice had a reduction in renal expression of the intracellular calcium-binding protein, calbindin-D, consistent with a specific defect in TRPV5-mediated renal calcium reabsorption. Thus, our findings indicate that the TRPV5 S682P mutant is functionally significant and study of HCALC1, a novel model for autosomal dominant hypercalciuria, may help further our understanding of renal calcium reabsorption and hypercalciuria.
AB - Hypercalciuria is a major cause of nephrolithiasis, and is a common and complex disorder involving genetic and environmental factors. Identification of genetic factors for monogenic forms of hypercalciuria is hampered by the limited availability of large families, and to facilitate such studies, we screened for hypercalciuria in mice from an N-ethyl-N-nitrosourea mutagenesis programme. We identified a mouse with autosomal dominant hypercalciuria (HCALC1). Linkage studies mapped the Hcalc1 locus to a 11.94 Mb region on chromosome 6 containing the transient receptor potential cation channel, subfamily V, members 5 (Trpv5) and 6 (Trpv6) genes. DNA sequence analysis of coding regions, intron-exon boundaries and promoters of Trpv5 and Trpv6 identified a novel T to C transition in codon 682 of TRPV5, mutating a conserved serine to a proline (S682P). Compared to wild-type littermates, heterozygous (Trpv5) and homozygous (Trpv5) mutant mice had hypercalciuria, polyuria, hyperphosphaturia and a more acidic urine, and ~10% of males developed tubulointerstitial nephritis. Trpv5 mice also had normal plasma parathyroid hormone but increased 1,25-dihydroxyvitamin D concentrations without increased bone resorption, consistent with a renal defect for the hypercalciuria. Expression of the S682P mutation in human embryonic kidney cells revealed that TRPV5-S682P-expressing cells had a lower baseline intracellular calcium concentration than wild-type TRPV5-expressing cells, suggesting an altered calcium permeability. Immunohistological studies revealed a selective decrease in TRPV5-expression from the renal distal convoluted tubules of Trpv5 and Trpv5 mice consistent with a trafficking defect. In addition, Trpv5 mice had a reduction in renal expression of the intracellular calcium-binding protein, calbindin-D, consistent with a specific defect in TRPV5-mediated renal calcium reabsorption. Thus, our findings indicate that the TRPV5 S682P mutant is functionally significant and study of HCALC1, a novel model for autosomal dominant hypercalciuria, may help further our understanding of renal calcium reabsorption and hypercalciuria.
UR - http://www.scopus.com/inward/record.url?scp=84873861072&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0055412
DO - 10.1371/journal.pone.0055412
M3 - Article
AN - SCOPUS:84873861072
VL - 8
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 1
M1 - e55412
ER -